A 44-year-old pregnant female patient gave stillbirth while being treated for pneumonia. She developed acute respiratory failure, which resulted in mechanical ventilator support. Diagnostic lung biopsy revealed a cryptogenic organizing pneumonia. The patient's condition deteriorated and a venous-venous extracorporeal membrane oxygenation was placed. She was listed for lung transplantation. Because of her worsening condition lung transplantation was performed despite positive cross matching result. She was treated with rituximab, intravenous immunoglobulin, and plasmapheresis and recovered without event. There is no sign of rejection at the time of last follow-up.
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CASE REPORT
A 44-year-old pregnant female patient at a gestational age 72.7 without a supply of oxygen. On the 43rd postoperative day, the T-cannula was removed, and the patient was discharged from the hospital with no specific complications on the 49th postoperative day. During the 3-month follow-up, no graft rejection was observed (Fig. 2) .
DISCUSSION
The prevention of graft rejection affects both the short-and long-term survival of the recipient. Therefore, the selection of the most compatible donor is a critical part of a successful transplantation. However, the shortage of donors and the worsening condition of recipients often force surgeons to proceed lung transplantations from incompatible donors.
A high PRA score (＞50% or ＞80%) is known to be a poor prognostic marker for transplantation [1] . Lee et al. [2] reported the graft rejection rate among renal allograft recipients. The graft rejection rate was 8.6% in recipients whose PRA score was zero. However, the graft rejection rate was 20% in recipients whose PRA score was less than 50%, and 25% when the PRA score was more than 50% (p＜0.05). and the ultimate elimination of DSA [6] .
Lung transplantation involving a positive cross-match result
is not yet a common practice. Yu et al. [7] reported a lung transplantation between an O-type blood donor and an A-type blood recipient. The recipient was treated with OKT3 immediately and did not show graft rejection during a 4-month follow-up.
In our case, the preoperative PRA level was high, and the preoperative cross-matching result was positive. To prevent acute graft rejection, the recipient was treated with rituximab, IVIG, and plasmapheresis. Although the long-term result remains to be determined, graft rejection was not observed 3 months after the transplant.
In conclusion, positive cross-match lung transplantation is a feasible option when combined with plasmapheresis and appropriate medication. However, a more delicate protocol for a positive cross-match is required. Moreover, the long-term results of positive cross-match lung transplantation are needed.
